Mesoblast (MESO) Equity Average (2017 - 2024)
Historic Equity Average for Mesoblast (MESO) over the last 10 years, with Q4 2024 value amounting to $470.8 million.
- Mesoblast's Equity Average fell 682.31% to $470.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $470.8 million, marking a year-over-year decrease of 682.31%. This contributed to the annual value of $491.1 million for FY2024, which is 167.08% down from last year.
- Latest data reveals that Mesoblast reported Equity Average of $470.8 million as of Q4 2024, which was down 682.31% from $494.5 million recorded in Q2 2024.
- In the past 5 years, Mesoblast's Equity Average ranged from a high of $591.2 million in Q2 2021 and a low of $470.8 million during Q4 2024
- In the last 5 years, Mesoblast's Equity Average had a median value of $511.4 million in 2022 and averaged $521.4 million.
- Per our database at Business Quant, Mesoblast's Equity Average surged by 1399.89% in 2021 and then crashed by 1422.25% in 2022.
- Mesoblast's Equity Average (Quarter) stood at $528.6 million in 2020, then grew by 3.6% to $547.6 million in 2021, then decreased by 6.61% to $511.4 million in 2022, then fell by 1.2% to $505.3 million in 2023, then fell by 6.82% to $470.8 million in 2024.
- Its Equity Average was $470.8 million in Q4 2024, compared to $494.5 million in Q2 2024 and $505.3 million in Q4 2023.